1. Corsellis JA GG, Norton AR. “Limbic encephalitis” And its association with carcinoma. Brain, 1968, 91(3): 481-496 2. Alamowitch S GF, Uchuya M, Re?é R, et al. Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain, 1997, 120(Pt 6): 923-928 3. Tüzün E DJ. Limbic encephalitis and variants: Classification, diagnosis and treatment. Neurologist, 2007, 13(5): 261-271 4. Graus F SA. Limbic encephalitis: an expanding concept. Neurology, 2008, 70(7): 500-501 5. Iizuka T SF, Ide T, Monzen T, et al. Anti-nmda receptor encephalitis in japan: Long-term outcome without tumor removal. Neurology, 2008, 70(7): 504-511 6. Jarius S HL, Stich O, Clover L, et al. Relative frequency of vgkc and ‘classical’paraneoplastic antibodies in patients with limbic encephalitis. J Neurol, 2008, 255(7): 1100-1101 7. Graus F SA, Lai M, Bruna J, et al. Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology, 2008, 71(12): 930-936 8. Thieben MJ LV, Boeve BF, Aksamit AJ, et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology, 2004, 62(7): 1177-1182 9. Vincent A BC, Schott JM, Baker I, et al. Potassium channel antibody-associated encephalopathy: A potentially immunotherapy-responsive form of limbic encephalitis. Brain, 2004, 127(Pt 3): 701-712 10. Graus F DJ, Antoine JC, Dalmau J, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry, 2004, 75(8): 1135-1134
……